Literature DB >> 18042252

Muramylpeptide shedding modulates cell sensing of Shigella flexneri.

Giulia Nigro1, Luigi Lembo Fazio, Maria Celeste Martino, Giacomo Rossi, Ivan Tattoli, Valeria Liparoti, Cristina De Castro, Antonio Molinaro, Dana J Philpott, Maria Lina Bernardini.   

Abstract

Bacterial infections trigger the activation of innate immunity through the interaction of pathogen-associated molecular patterns (PAMPs) with pattern recognition molecules (PRMs). The nucleotide-binding oligomerization domain (Nod) proteins are intracellular PRMs that recognize muramylpeptides contained in peptidoglycan (PGN) of bacteria. It is still unclear how Nod1 physically interacts with PGN, a structure internal to the Gram-negative bacterial envelope. To contribute to the understanding of this process, we demonstrate that, like Escherichia coli, Bordetella pertussis and Neisseria gonorrheae, the Gram-negative pathogen Shigella spontaneously releases PGN fragments and that this process can be increased by inactivating either ampG or mppA, genes involved in PGN recycling. Both Shigella mutants, but especially the strain carrying the mppA deletion, trigger Nod1-mediated NF-kappaB activation to a greater extent than the wild-type strain. Likewise, muramylpeptides spontaneously shed by Shigella are able per se to trigger a Nod1-mediated response consistent with the relative amount. Finally, we found that qualitative changes in muramylpeptide shedding can alter in vivo host responses to Shigella infection. Our findings support the idea that muramylpeptides released by pathogens during infection could modulate the immune response through Nod proteins and thereby influence the outcome of disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042252     DOI: 10.1111/j.1462-5822.2007.01075.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  39 in total

Review 1.  Messenger functions of the bacterial cell wall-derived muropeptides.

Authors:  Marc A Boudreau; Jed F Fisher; Shahriar Mobashery
Journal:  Biochemistry       Date:  2012-03-27       Impact factor: 3.162

Review 2.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 3.  Exit from dormancy in microbial organisms.

Authors:  Jonathan Dworkin; Ishita M Shah
Journal:  Nat Rev Microbiol       Date:  2010-10-25       Impact factor: 60.633

Review 4.  Modifications to the peptidoglycan backbone help bacteria to establish infection.

Authors:  Kimberly M Davis; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 5.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 6.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

7.  Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response.

Authors:  Nikolaos Mavrogiorgos; Samrawit Mekasha; Yibin Yang; Michelle A Kelliher; Robin R Ingalls
Journal:  Innate Immun       Date:  2013-07-24       Impact factor: 2.680

8.  Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.

Authors:  Benjamin K Billips; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

Review 9.  Emerging roles of immunostimulatory oral bacteria in periodontitis development.

Authors:  Yizu Jiao; Mizuho Hasegawa; Naohiro Inohara
Journal:  Trends Microbiol       Date:  2014-01-13       Impact factor: 17.079

10.  Innate immune recognition of Yersinia pseudotuberculosis type III secretion.

Authors:  Victoria Auerbuch; Douglas T Golenbock; Ralph R Isberg
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.